vs

Side-by-side financial comparison of CorMedix Inc. (CRMD) and DigitalOcean Holdings, Inc. (DOCN). Click either name above to swap in a different company.

DigitalOcean Holdings, Inc. is the larger business by last-quarter revenue ($242.4M vs $128.6M, roughly 1.9× CorMedix Inc.). CorMedix Inc. produced more free cash flow last quarter ($92.7M vs $31.1M).

CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.

DigitalOcean Holdings, Inc. is an American multinational technology company and cloud service provider. The company is headquartered in Broomfield, Colorado, US, with 15 globally distributed data centers. DigitalOcean provides developers, startups, and SMBs with cloud infrastructure-as-a-service platforms.

CRMD vs DOCN — Head-to-Head

Bigger by revenue
DOCN
DOCN
1.9× larger
DOCN
$242.4M
$128.6M
CRMD
More free cash flow
CRMD
CRMD
$61.6M more FCF
CRMD
$92.7M
$31.1M
DOCN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRMD
CRMD
DOCN
DOCN
Revenue
$128.6M
$242.4M
Net Profit
$25.7M
Gross Margin
83.4%
58.7%
Operating Margin
46.0%
16.0%
Net Margin
10.6%
Revenue YoY
18.3%
Net Profit YoY
40.5%
EPS (diluted)
$0.20
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRMD
CRMD
DOCN
DOCN
Q4 25
$128.6M
$242.4M
Q3 25
$104.3M
$229.6M
Q2 25
$39.7M
$218.7M
Q1 25
$39.1M
$210.7M
Q4 24
$204.9M
Q3 24
$198.5M
Q2 24
$192.5M
Q1 24
$184.7M
Net Profit
CRMD
CRMD
DOCN
DOCN
Q4 25
$25.7M
Q3 25
$108.6M
$158.4M
Q2 25
$19.8M
$37.0M
Q1 25
$20.6M
$38.2M
Q4 24
$18.3M
Q3 24
$32.9M
Q2 24
$19.1M
Q1 24
$14.1M
Gross Margin
CRMD
CRMD
DOCN
DOCN
Q4 25
83.4%
58.7%
Q3 25
89.3%
59.6%
Q2 25
95.3%
59.9%
Q1 25
95.9%
61.4%
Q4 24
57.1%
Q3 24
60.2%
Q2 24
61.0%
Q1 24
60.7%
Operating Margin
CRMD
CRMD
DOCN
DOCN
Q4 25
46.0%
16.0%
Q3 25
49.2%
19.6%
Q2 25
49.2%
16.3%
Q1 25
51.5%
17.9%
Q4 24
15.9%
Q3 24
12.4%
Q2 24
11.6%
Q1 24
6.2%
Net Margin
CRMD
CRMD
DOCN
DOCN
Q4 25
10.6%
Q3 25
104.1%
69.0%
Q2 25
49.9%
16.9%
Q1 25
52.8%
18.1%
Q4 24
8.9%
Q3 24
16.6%
Q2 24
9.9%
Q1 24
7.7%
EPS (diluted)
CRMD
CRMD
DOCN
DOCN
Q4 25
$0.20
$0.23
Q3 25
$1.26
$1.51
Q2 25
$0.28
$0.39
Q1 25
$0.30
$0.39
Q4 24
$0.21
Q3 24
$0.33
Q2 24
$0.20
Q1 24
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRMD
CRMD
DOCN
DOCN
Cash + ST InvestmentsLiquidity on hand
$148.5M
$254.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$405.3M
$-28.7M
Total Assets
$826.1M
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRMD
CRMD
DOCN
DOCN
Q4 25
$148.5M
$254.5M
Q3 25
$55.7M
$236.6M
Q2 25
$190.7M
$387.7M
Q1 25
$77.5M
$360.4M
Q4 24
$428.4M
Q3 24
$439.9M
Q2 24
$443.1M
Q1 24
$419.1M
Total Debt
CRMD
CRMD
DOCN
DOCN
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
Q1 25
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CRMD
CRMD
DOCN
DOCN
Q4 25
$405.3M
$-28.7M
Q3 25
$374.1M
$-69.6M
Q2 25
$220.6M
$-175.2M
Q1 25
$114.9M
$-210.7M
Q4 24
$-203.0M
Q3 24
$-211.7M
Q2 24
$-253.8M
Q1 24
$-286.1M
Total Assets
CRMD
CRMD
DOCN
DOCN
Q4 25
$826.1M
$1.8B
Q3 25
$750.9M
$1.7B
Q2 25
$252.6M
$1.7B
Q1 25
$149.6M
$1.6B
Q4 24
$1.6B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRMD
CRMD
DOCN
DOCN
Operating Cash FlowLast quarter
$94.5M
$57.3M
Free Cash FlowOCF − Capex
$92.7M
$31.1M
FCF MarginFCF / Revenue
72.1%
12.8%
Capex IntensityCapex / Revenue
1.3%
10.8%
Cash ConversionOCF / Net Profit
2.23×
TTM Free Cash FlowTrailing 4 quarters
$172.8M
$180.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRMD
CRMD
DOCN
DOCN
Q4 25
$94.5M
$57.3M
Q3 25
$30.9M
$95.8M
Q2 25
$30.0M
$92.4M
Q1 25
$19.7M
$64.1M
Q4 24
$71.3M
Q3 24
$73.4M
Q2 24
$71.3M
Q1 24
$66.7M
Free Cash Flow
CRMD
CRMD
DOCN
DOCN
Q4 25
$92.7M
$31.1M
Q3 25
$30.4M
$88.0M
Q2 25
$30.0M
$59.3M
Q1 25
$19.7M
$2.1M
Q4 24
$26.1M
Q3 24
$16.0M
Q2 24
$39.5M
Q1 24
$23.0M
FCF Margin
CRMD
CRMD
DOCN
DOCN
Q4 25
72.1%
12.8%
Q3 25
29.1%
38.3%
Q2 25
75.4%
27.1%
Q1 25
50.5%
1.0%
Q4 24
12.7%
Q3 24
8.1%
Q2 24
20.5%
Q1 24
12.5%
Capex Intensity
CRMD
CRMD
DOCN
DOCN
Q4 25
1.3%
10.8%
Q3 25
0.5%
3.4%
Q2 25
0.1%
15.2%
Q1 25
0.0%
29.4%
Q4 24
22.1%
Q3 24
28.9%
Q2 24
16.6%
Q1 24
23.6%
Cash Conversion
CRMD
CRMD
DOCN
DOCN
Q4 25
2.23×
Q3 25
0.28×
0.60×
Q2 25
1.51×
2.50×
Q1 25
0.96×
1.68×
Q4 24
3.91×
Q3 24
2.23×
Q2 24
3.73×
Q1 24
4.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRMD
CRMD

Acquisition Of Melinta$52.9M41%
Melinta Portfolio$45.5M35%
Other$18.6M14%
Contract Revenue$7.4M6%
BARDA Agreement$4.2M3%

DOCN
DOCN

Scalers$84.3M35%
Scalers Plus$69.9M29%
Builders$64.1M26%
Learners Testers And Other$24.1M10%

Related Comparisons